1 |
Bagur R, Hajnoczky G. Intracellular Ca2+ sensing: its role in calcium homeostasis and signaling. Mol Cell. 2017;66:780-788.
DOI
|
2 |
Yang PC, Jafri MS. Ca2+ signaling in T lymphocytes: the interplay of the endoplasmic reticulum, mitochondria, membrane potential, and CRAC channels on transcription factor activation. Heliyon. 2020;6:e03526.
DOI
|
3 |
Jafri MS, Keizer J. On the roles of Ca2+ diffusion, Ca2+ buffers, and the endoplasmic reticulum in IP3-induced Ca2+ waves. Biophys J. 1995;69:2139-2153.
DOI
|
4 |
Vaeth M, Kahlfuss S, Feske S. CRAC channels and calcium signaling in T cell-mediated immunity. Trends Immunol. 2020;41:878-901.
DOI
|
5 |
Feske S. Calcium signals in lymphocyte activation and disease. Cell Commun Signal. 2009;7(Suppl 1):A76.
DOI
|
6 |
Prakriya M, Lewis RS. Store-operated calcium channels. Physiol Rev. 2015;95:1383-1436.
DOI
|
7 |
McCarl CA, Picard C, Khalil S, Kawasaki T, Rother J, Papolos A, Kutok J, Hivroz C, Ledeist F, Plogmann K, Ehl S, Notheis G, Albert MH, Belohradsky BH, Kirschner J, Rao A, Fischer A, Feske S. ORAI1 deficiency and lack of store-operated Ca2+ entry cause immunodeficiency, myopathy, and ectodermal dysplasia. J Allergy Clin Immunol. 2009;124:1311-1318.e7.
DOI
|
8 |
Yan S, Chen W, Zhang Y, Li J, Chen X. Calcium release-activated calcium modulator 1 as a therapeutic target in allergic skin diseases. Life Sci. 2019;228:152-157.
DOI
|
9 |
Lioudyno MI, Kozak JA, Penna A, Safrina O, Zhang SL, Sen D, Roos J, Stauderman KA, Cahalan MD. Orai1 and STIM1 move to the immunological synapse and are up-regulated during T cell activation. Proc Natl Acad Sci U S A. 2008;105:2011-2016.
DOI
|
10 |
Aki A, Tanaka K, Nagaoka N, Kimura T, Baba D, Onodera Y, Wada T, Maeda H, Nakanishi T, Agatsuma T, Komai T. Anti-ORAI1 antibody DS-2741a, a specific CRAC channel blocker, shows ideal therapeutic profiles for allergic disease via suppression of aberrant T-cell and mast cell activation. FASEB Bioadv. 2020;2:478-488.
DOI
|
11 |
Kim HJ, Nam YR, Nam JH. Flos Magnoliae inhibits chloride secretion via ANO1 inhibition in Calu-3 cells. Am J Chin Med. 2018;46:1079-1092.
DOI
|
12 |
Shin TY, Kim DK, Chae BS, Lee EJ. Antiallergic action of Magnolia officinalis on immediate hypersensitivity reaction. Arch Pharm Res. 2001;24:249-255.
DOI
|
13 |
Kim HJ, Woo J, Nam YR, Nam JH, Kim WK. Flos Magnoliae and its constituent linoleic acid suppress T lymphocyte activation via store-operated calcium entry. Am J Chin Med. 2019;47:1627-1641.
DOI
|
14 |
Shen Y, Pang EC, Xue CC, Zhao ZZ, Lin JG, Li CG. Inhibitions of mast cell-derived histamine release by different Flos Magnoliae species in rat peritoneal mast cells. Phytomedicine. 2008;15:808-814.
DOI
|
15 |
Nguyen TTM, Lee HS, Nguyen TT, Ngo TQM, Jun CD, Min BS, Kim JA. Four new lignans and IL-2 inhibitors from Magnoliae Flos. Chem Pharm Bull (Tokyo). 2017;65:840-847.
DOI
|
16 |
Nam JH, Jung HW, Chin YW, Yang WM, Bae HS, Kim WK. Spirodela polyrhiza extract modulates the activation of atopic dermatitisrelated ion channels, Orai1 and TRPV3, and inhibits mast cell degranulation. Pharm Biol. 2017;55:1324-1329.
DOI
|
17 |
Kim HJ, Nam YR, Kim EJ, Nam JH, Kim WK. Spirodela polyrhiza and its chemical constituent vitexin exert anti-allergic effect via ORAI1 channel inhibition. Am J Chin Med. 2018;46:1243-1261.
DOI
|
18 |
Vig M, DeHaven WI, Bird GS, Billingsley JM, Wang H, Rao PE, Hutchings AB, Jouvin MH, Putney JW, Kinet JP. Defective mast cell effector functions in mice lacking the CRACM1 pore subunit of store-operated calcium release-activated calcium channels. Nat Immunol. 2008;9:89-96.
DOI
|
19 |
Woo JH, Nam DY, Kim HJ, Hong PTL, Kim WK, Nam JH. Nootkatol prevents ultraviolet radiation-induced photoaging via ORAI1 and TRPV1 inhibition in melanocytes and keratinocytes. Korean J Physiol Pharmacol. 2021;25:87-94.
DOI
|
20 |
Nam JH, Lee DU. Foeniculum vulgare extract and its constituent, trans-anethole, inhibit UV-induced melanogenesis via ORAI1 channel inhibition. J Dermatol Sci. 2016;84:305-313.
DOI
|
21 |
Kobayashi S, Kobayashi H, Matsuno H, Kimura I, Kimura M. Inhibitory effects of anti-rheumatic drugs containing magnosalin, a compound from 'Shin-i' (Flos magnoliae), on the proliferation of synovial cells in rheumatoid arthritis models. Immunopharmacology. 1998;39:139-147.
DOI
|
22 |
Ma P, Che D, Zhao T, Zhang Y, Li C, An H, Zhang T, He H. Magnolin inhibits IgE/Ag-induced allergy in vivo and in vitro. Int Immunopharmacol. 2019;76:105867.
DOI
|
23 |
Liang Y, Zhang X, Zou J, Shi Y, Wang Y, Tai J, Yang Y, Zhou X, Guo D, Wang J, Cheng J, Yang M. Pharmacology mechanism of Flos magnoliae and Centipeda minima for treating allergic rhinitis based on pharmacology network. Drug Dev Ind Pharm. 2019;45:1547-1555.
DOI
|
24 |
Jung YS, Weon JB, Yang WS, Ryu G, Ma CJ. Neuroprotective effects of Magnoliae Flos extract in mouse hippocampal neuronal cells. Sci Rep. 2018;8:9693.
DOI
|
25 |
Wang X, Cheng Y, Xue H, Yue Y, Zhang W, Li X. Fargesin as a potential β1 adrenergic receptor antagonist protects the hearts against ischemia/reperfusion injury in rats via attenuating oxidative stress and apoptosis. Fitoterapia. 2015;105:16-25.
DOI
|
26 |
Junttila IS. Tuning the cytokine responses: an update on interleukin (IL)-4 and IL-13 receptor complexes. Front Immunol. 2018;9:888.
DOI
|
27 |
Kim GC, Lee SG, Park BS, Kim JY, Song YS, Kim JM, Yoo KS, Huh GY, Jeong MH, Lim YJ, Kim HM, Yoo YH. Magnoliae flos induces apoptosis of RBL-2H3 cells via mitochondria and caspase. Int Arch Allergy Immunol. 2003;131:101-110.
DOI
|
28 |
Galli SJ, Gaudenzio N, Tsai M. Mast cells in inflammation and disease: recent progress and ongoing concerns. Annu Rev Immunol. 2020;38:49-77.
DOI
|
29 |
Pham TH, Kim MS, Le MQ, Song YS, Bak Y, Ryu HW, Oh SR, Yoon DY. Fargesin exerts anti-inflammatory effects in THP-1 monocytes by suppressing PKC-dependent AP-1 and NF-ĸB signaling. Phytomedicine. 2017;24:96-103.
DOI
|
30 |
Yue B, Ren YJ, Zhang JJ, Luo XP, Yu ZL, Ren GY, Sun AN, Deng C, Wang ZT, Dou W. Anti-inflammatory effects of fargesin on chemically induced inflammatory bowel disease in mice. Molecules. 2018;23:1380.
DOI
|
31 |
Ozdemir C, Akdis M, Akdis CA. Nature of regulatory T cells in the context of allergic disease. Allergy Asthma Clin Immunol. 2008;4:106-110.
DOI
|
32 |
Fu T, Chai B, Shi Y, Dang Y, Ye X. Fargesin inhibits melanin synthesis in murine malignant and immortalized melanocytes by regulating PKA/CREB and P38/MAPK signaling pathways. J Dermatol Sci. 2019;94:213-219.
DOI
|
33 |
Wang G, Gao JH, He LH, Yu XH, Zhao ZW, Zou J, Wen FJ, Zhou L, Wan XJ, Tang CK. Fargesin alleviates atherosclerosis by promoting reverse cholesterol transport and reducing inflammatory response. Biochim Biophys Acta Mol Cell Biol Lipids. 2020;1865:158633.
DOI
|
34 |
Rajan TV. The Gell-Coombs classification of hypersensitivity reactions: a re-interpretation. Trends Immunol. 2003;24:376-379.
DOI
|
35 |
Galli SJ, Tsai M, Piliponsky AM. The development of allergic inflammation. Nature. 2008;454:445-454.
DOI
|
36 |
Chassin H, Geering B, Schukur L, Auslander D, Lang B, Fussenegger M. Sensing and responding to allergic response cytokines through a genetically encoded circuit. Nat Commun. 2017;8:1101.
DOI
|
37 |
Lenon GB, Xue CC, Story DF, Thien FC, McPhee S, Li CG. Inhibition of release of inflammatory mediators in primary and cultured cells by a Chinese herbal medicine formula for allergic rhinitis. Chin Med. 2007;2:2.
DOI
|
38 |
Izquierdo JH, Bonilla-Abadia F, Canas CA, Tobon GJ. Calcium, channels, intracellular signaling and autoimmunity. Reumatol Clin. 2014;10:43-47.
DOI
|
39 |
Ma HT, Beaven MA. Regulation of Ca2+ signaling with particular focus on mast cells. Crit Rev Immunol. 2009;29:155-186.
DOI
|
40 |
Feske S, Wulff H, Skolnik EY. Ion channels in innate and adaptive immunity. Annu Rev Immunol. 2015;33:291-353.
DOI
|
41 |
Feske S. CRAC channels and disease - from human CRAC channelopathies and animal models to novel drugs. Cell Calcium. 2019;80:112-116.
DOI
|
42 |
Holgate ST, Broide D. New targets for allergic rhinitis--a disease of civilization. Nat Rev Drug Discov. 2003;2:902-914.
|
43 |
Lee CJ, Lee MH, Yoo SM, Choi KI, Song JH, Jang JH, Oh SR, Ryu HW, Lee HS, Surh YJ, Cho YY. Magnolin inhibits cell migration and invasion by targeting the ERKs/RSK2 signaling pathway. BMC Cancer. 2015;15:576.
DOI
|
44 |
Lim H, Son KH, Bae KH, Hung TM, Kim YS, Kim HP. 5-lipoxygenase-inhibitory constituents from Schizandra fructus and Magnolia flos. Phytother Res. 2009;23:1489-1492.
DOI
|
45 |
Zhang X, Qian F, Tan JJ, Guo FJ, Kulka M, Xu JW, Li YM. Bioassayguided isolation of bisepoxylignans from the flower buds of Magnolia biondii Pamp and their antiallergic effects. RSC Advances. 2017;7:34236-34243.
DOI
|
46 |
Lin Y, Xu J, Jia Q, Sun W, Fu J, Lv Y, Han S. Cell membrane chromatography coupled online with LC-MS to screen anti-anaphylactoid components from Magnolia biondii Pamp. targeting on Mas-related G protein-coupled receptor X2. J Sep Sci. 2020;43:2571-2578.
DOI
|
47 |
Wang J, Zhang S, Huang K, Shi L, Zhang Q. Magnolin inhibits proliferation and invasion of breast cancer MDA-MB-231 cells by targeting the ERK1/2 signaling pathway. Chem Pharm Bull (Tokyo). 2020;68:421-427.
DOI
|
48 |
Cho JY, Yoo ES, Baik KU, Park MH. Eudesmin inhibits tumor necrosis factor-alpha production and T cell proliferation. Arch Pharm Res. 1999;22:348-353.
DOI
|